Wyatt Unger

Dr. Unger received his B.A. in economics from Northwestern University, M.D. from the University of Arizona College of Medicine with Alpha Omega Alpha honors, and MBA from the University of Arizona Eller College of Business. Dr. Unger completed diagnostic radiology residency training at Arizona, where he also completed a fellowship in Abdominal MRI imaging. Dr. Unger has authored multiple peer-reviewed abstracts and journal publications, worked as a consultant in clinical development and clinical trial design for Nuvox Pharmaceutical and serves as the Chief Medical Officer for Microvascular Therapeutics where he is overseeing clinical development and clinical trial design for their pharmaceutical candidate MVT-100.